This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
Musashi-1 Antibody
catalog :
NBP2-24681
quantity :
0.1 mg (also 0.025 mg)
price :
279 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat, dogs
application :
western blot
product information
SKU :
NBP2-24681
product name :
Musashi-1 Antibody
unit size :
0.1 mg (also 0.025 mg)
Description :
The Musashi-1 Antibody from Novus is a rabbit polyclonal antibody to Musashi-1. This antibody reacts with human, mouse, rat, canine, equine, primate. The Musashi-1 Antibody has been validated for the following applications: Western Blot.
target :
Musashi-1
category :
Primary Antibodies
buffer :
0.2 ml PBS and 0.05% BSA
clonality :
Polyclonal
concentration :
0.5 mg/ml
conjugate :
Unconjugated
host :
Rabbit
immunogen :
A portion of amino acids 200 to 250 of human Musashi-1 was used as immunogen.
isotype :
IgG
purity :
Protein A purified
species :
Human, Mouse, Rat, Canine, Equine, Primate
gene symbol :
MSI1
catalog number base :
NBP2-24681
accessionNumbers :
O43347
applications :
Western Blot
2020 Proposedprice USD :
279 USD
alt names :
Musashi (Drosophila) homolog 1, musashi homolog 1 (Drosophila), Musashi-1, RNA-binding protein Musashi homolog 1
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
company information

Novus Biologicals
8100 Southpark Way, A-8
Littleton, CO 80120
Littleton, CO 80120
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
questions and comments